Announce Date | 03/04/2025 |
EPS Normalized Actual | $0.3 (Miss by $-0.28) |
EPS GAAP Actual | $0.3 (Miss by $-0.28) |
Revenue Actual | $0.139753B |
Revenue Surprise | Beat by $139.753M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Apr 2029 | 6.35 | 26.06 | 5.94605 | 7.05337 | 0 |
Apr 2028 | 5.25 | 31.52 | 5.07062 | 5.44734 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.0626 | -0.0626 | 0.139753B | -123.14% | 139.75M |
FQ4 2024 (Oct 2024) | -0.76 | -0.76 | 0.121252B | -49.12% | 121.25M |
FQ3 2024 (Jul 2024) | 0.76 | 0.76 | 0.319008B | 25.1% | 319.01M |
FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 0.196979B | 5.55% | 196.98M |
FQ1 2024 (Jan 2024) | 0.0005 | 0.0005 | 0.311846B | 53.16% | 311.85M |
FQ4 2023 (Oct 2023) | 0.66 | 0.66 | 0.180816B | 43.71% | 180.82M |
FQ3 2023 (Jul 2023) | 0.84 | 0.84 | 0.238942B | 61.97% | 238.94M |
FQ2 2023 (Apr 2023) | -6.29 | -6.29 | 0.186041B | 100% | 186.04M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 1.34 | -- | 1.28689 | 1.39122 | 3 |
FQ1 2027 (Jan 2027) | 1.26 | -- | 1.21006 | 1.30817 | 3 |
FQ4 2026 (Oct 2026) | 1.28 | -- | 1.22927 | 1.32893 | 3 |
FQ3 2026 (Jul 2026) | 1.24 | -- | 1.19086 | 1.2874 | 3 |
FQ2 2026 (Apr 2026) | 1.385 | -- | 1.34304 | 1.42483 | 1 |
FQ1 2026 (Jan 2026) | 1.11 | 105.64 | 1.11 | 1.11 | 1 |
FQ4 2025 (Oct 2025) | 0.965 | 178.76 | 0.91401 | 1.02474 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ2 2027 (Apr 2027) | 0.27B | -- | 0.26B | 0.28B | 4 |
FQ1 2027 (Jan 2027) | 0.25B | -- | 0.24B | 0.26B | 4 |
FQ4 2026 (Oct 2026) | 0.25B | -- | 0.24B | 0.26B | 4 |
FQ3 2026 (Jul 2026) | 0.24B | -- | 0.24B | 0.25B | 4 |
FQ2 2026 (Apr 2026) | 0.3B | -- | 0.29B | 0.31B | 2 |
FQ1 2026 (Jan 2026) | 0.26B | 45.91 | 0.26B | 0.26B | 1 |
FQ4 2025 (Oct 2025) | 0.22B | 45.26 | 0.21B | 0.23B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
3
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | -0.0626 | -0.0626 | 100% | |
FQ4 2024 (Oct 2024) | -0.76 | -0.76 | 100% | |
FQ3 2024 (Jul 2024) | 0.76 | 0.76 | 100% | |
FQ2 2024 (Apr 2024) | 0.22 | 0.22 | 100% | |
FQ1 2024 (Jan 2024) | 0.0005 | 0.0005 | 100% | |
FQ4 2023 (Oct 2023) | 0.66 | 0.66 | 100% | |
FQ3 2023 (Jul 2023) | 0.84 | 0.84 | 100% | |
FQ2 2023 (Apr 2023) | -6.29 | -6.29 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Jan 2025) | $0B | $0.14B | $139.75M | 100% |
FQ4 2024 (Oct 2024) | $0B | $0.12B | $121.25M | 100% |
FQ3 2024 (Jul 2024) | $0B | $0.32B | $319.01M | 100% |
FQ2 2024 (Apr 2024) | $0B | $0.2B | $196.98M | 100% |
FQ1 2024 (Jan 2024) | $0B | $0.31B | $311.85M | 100% |
FQ4 2023 (Oct 2023) | $0B | $0.18B | $180.82M | 100% |
FQ3 2023 (Jul 2023) | $0B | $0.24B | $238.94M | 100% |
FQ2 2023 (Apr 2023) | $0B | $0.19B | $186.04M | 100% |